nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—SIGMAR1—amyotrophic lateral sclerosis	0.544	1	CbGaD
Clomifene—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.221	0.691	CbGbCtD
Clomifene—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.0988	0.309	CbGbCtD
Clomifene—Exomphalos—Riluzole—amyotrophic lateral sclerosis	0.0316	0.268	CcSEcCtD
Clomifene—Talipes—Riluzole—amyotrophic lateral sclerosis	0.0181	0.154	CcSEcCtD
Clomifene—Congenital central nervous system anomaly—Riluzole—amyotrophic lateral sclerosis	0.0181	0.154	CcSEcCtD
Clomifene—Thyroid neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00948	0.0803	CcSEcCtD
Clomifene—Uterine haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00313	0.0265	CcSEcCtD
Clomifene—Embolism—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0144	CcSEcCtD
Clomifene—Cyst—Riluzole—amyotrophic lateral sclerosis	0.00164	0.0139	CcSEcCtD
Clomifene—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00154	0.0131	CcSEcCtD
Clomifene—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00985	CcSEcCtD
Clomifene—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00973	CcSEcCtD
Clomifene—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00926	CcSEcCtD
Clomifene—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00926	CcSEcCtD
Clomifene—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00869	CcSEcCtD
Clomifene—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.000988	0.00837	CcSEcCtD
Clomifene—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.000949	0.00804	CcSEcCtD
Clomifene—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.000921	0.0078	CcSEcCtD
Clomifene—Deafness—Riluzole—amyotrophic lateral sclerosis	0.000887	0.00751	CcSEcCtD
Clomifene—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000845	0.00715	CcSEcCtD
Clomifene—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.000794	0.00672	CcSEcCtD
Clomifene—Migraine—Riluzole—amyotrophic lateral sclerosis	0.000781	0.00662	CcSEcCtD
Clomifene—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000781	0.00662	CcSEcCtD
Clomifene—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.000775	0.00656	CcSEcCtD
Clomifene—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000752	0.00637	CcSEcCtD
Clomifene—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00069	0.00585	CcSEcCtD
Clomifene—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000672	0.0057	CcSEcCtD
Clomifene—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000657	0.00557	CcSEcCtD
Clomifene—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.000634	0.00537	CcSEcCtD
Clomifene—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000624	0.00529	CcSEcCtD
Clomifene—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.000596	0.00505	CcSEcCtD
Clomifene—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000549	0.00465	CcSEcCtD
Clomifene—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000519	0.0044	CcSEcCtD
Clomifene—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00049	0.00415	CcSEcCtD
Clomifene—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000485	0.00411	CcSEcCtD
Clomifene—Tamoxifen—SIGMAR1—amyotrophic lateral sclerosis	0.000477	1	CrCbGaD
Clomifene—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000471	0.00399	CcSEcCtD
Clomifene—Tension—Riluzole—amyotrophic lateral sclerosis	0.000469	0.00397	CcSEcCtD
Clomifene—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000464	0.00393	CcSEcCtD
Clomifene—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000462	0.00392	CcSEcCtD
Clomifene—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000429	0.00364	CcSEcCtD
Clomifene—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000429	0.00363	CcSEcCtD
Clomifene—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000422	0.00358	CcSEcCtD
Clomifene—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00042	0.00356	CcSEcCtD
Clomifene—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000414	0.00351	CcSEcCtD
Clomifene—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000413	0.00349	CcSEcCtD
Clomifene—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000407	0.00345	CcSEcCtD
Clomifene—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000407	0.00345	CcSEcCtD
Clomifene—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000407	0.00345	CcSEcCtD
Clomifene—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000405	0.00343	CcSEcCtD
Clomifene—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00039	0.0033	CcSEcCtD
Clomifene—Shock—Riluzole—amyotrophic lateral sclerosis	0.000384	0.00325	CcSEcCtD
Clomifene—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000381	0.00322	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000355	0.00301	CcSEcCtD
Clomifene—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000353	0.00299	CcSEcCtD
Clomifene—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00035	0.00297	CcSEcCtD
Clomifene—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000348	0.00295	CcSEcCtD
Clomifene—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000336	0.00285	CcSEcCtD
Clomifene—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000334	0.00283	CcSEcCtD
Clomifene—Pain—Riluzole—amyotrophic lateral sclerosis	0.000334	0.00283	CcSEcCtD
Clomifene—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00031	0.00262	CcSEcCtD
Clomifene—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000308	0.00261	CcSEcCtD
Clomifene—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000287	0.00243	CcSEcCtD
Clomifene—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00028	0.00237	CcSEcCtD
Clomifene—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000276	0.00234	CcSEcCtD
Clomifene—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000267	0.00226	CcSEcCtD
Clomifene—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000258	0.00218	CcSEcCtD
Clomifene—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000248	0.0021	CcSEcCtD
Clomifene—Rash—Riluzole—amyotrophic lateral sclerosis	0.000246	0.00208	CcSEcCtD
Clomifene—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000246	0.00208	CcSEcCtD
Clomifene—Headache—Riluzole—amyotrophic lateral sclerosis	0.000244	0.00207	CcSEcCtD
Clomifene—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000232	0.00196	CcSEcCtD
Clomifene—ESR1—hindbrain—amyotrophic lateral sclerosis	6.34e-05	0.0742	CbGeAlD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	6.17e-05	0.00365	CbGpPWpGaD
Clomifene—EBP—Metabolism—GSR—amyotrophic lateral sclerosis	6.07e-05	0.00359	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	5.98e-05	0.00354	CbGpPWpGaD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	5.98e-05	0.00354	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	5.97e-05	0.00354	CbGpPWpGaD
Clomifene—CYP1A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.95e-05	0.00352	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	5.8e-05	0.00344	CbGpPWpGaD
Clomifene—ESR1—Plasma membrane estrogen receptor signaling—MMP9—amyotrophic lateral sclerosis	5.75e-05	0.0034	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	5.69e-05	0.00337	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	5.64e-05	0.00334	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.53e-05	0.00327	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	5.46e-05	0.00323	CbGpPWpGaD
Clomifene—CYP11A1—Corticotropin-releasing hormone—CASP3—amyotrophic lateral sclerosis	5.37e-05	0.00318	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	5.34e-05	0.00317	CbGpPWpGaD
Clomifene—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	5.33e-05	0.00316	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—ZNF470—amyotrophic lateral sclerosis	5.22e-05	0.00309	CbGpPWpGaD
Clomifene—CYP2A6—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	5.2e-05	0.00308	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—TPK1—amyotrophic lateral sclerosis	5.19e-05	0.00307	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—VAPB—amyotrophic lateral sclerosis	5.19e-05	0.00307	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	5.09e-05	0.00301	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	5.06e-05	0.003	CbGpPWpGaD
Clomifene—EBP—Metabolism—CHAT—amyotrophic lateral sclerosis	4.98e-05	0.00295	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.84e-05	0.00287	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.75e-05	0.00281	CbGpPWpGaD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	4.71e-05	0.00279	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	4.6e-05	0.00272	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.58e-05	0.00271	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.55e-05	0.00269	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	4.52e-05	0.00268	CbGpPWpGaD
Clomifene—CYP19A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.49e-05	0.00266	CbGpPWpGaD
Clomifene—CYP11A1—medulla oblongata—amyotrophic lateral sclerosis	4.48e-05	0.0525	CbGeAlD
Clomifene—ESR1—Gene Expression—SMN1—amyotrophic lateral sclerosis	4.44e-05	0.00263	CbGpPWpGaD
Clomifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	4.43e-05	0.00262	CbGpPWpGaD
Clomifene—CYP19A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.42e-05	0.00262	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.41e-05	0.00261	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	4.33e-05	0.00257	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	4.32e-05	0.00256	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.23e-05	0.00251	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	4.22e-05	0.0025	CbGpPWpGaD
Clomifene—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.19e-05	0.00248	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.19e-05	0.00248	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—FIG4—amyotrophic lateral sclerosis	4.15e-05	0.00246	CbGpPWpGaD
Clomifene—CYP2A6—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	4.13e-05	0.00244	CbGpPWpGaD
Clomifene—CYP2A6—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	4.07e-05	0.00241	CbGpPWpGaD
Clomifene—ESR1—embryo—amyotrophic lateral sclerosis	3.96e-05	0.0464	CbGeAlD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	3.96e-05	0.00234	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—ZNF746—amyotrophic lateral sclerosis	3.96e-05	0.00234	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.89e-05	0.00231	CbGpPWpGaD
Clomifene—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	3.79e-05	0.00225	CbGpPWpGaD
Clomifene—ESR1—LKB1 signaling events—TP53—amyotrophic lateral sclerosis	3.75e-05	0.00222	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—DAO—amyotrophic lateral sclerosis	3.75e-05	0.00222	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—MMP9—amyotrophic lateral sclerosis	3.75e-05	0.00222	CbGpPWpGaD
Clomifene—CYP1A1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.7e-05	0.00219	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.66e-05	0.00217	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	3.64e-05	0.00216	CbGpPWpGaD
Clomifene—ESR1—brainstem—amyotrophic lateral sclerosis	3.63e-05	0.0425	CbGeAlD
Clomifene—CYP2A6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.57e-05	0.00211	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	3.56e-05	0.00211	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.44e-05	0.00204	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.44e-05	0.00204	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	3.39e-05	0.00201	CbGpPWpGaD
Clomifene—CYP11A1—nervous system—amyotrophic lateral sclerosis	3.37e-05	0.0394	CbGeAlD
Clomifene—CYP11A1—central nervous system—amyotrophic lateral sclerosis	3.24e-05	0.038	CbGeAlD
Clomifene—KCNH2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	3.24e-05	0.00192	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	3.22e-05	0.0019	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.21e-05	0.0019	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	3.16e-05	0.00187	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.14e-05	0.00186	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	3.12e-05	0.00185	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.11e-05	0.00184	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	3.07e-05	0.00182	CbGpPWpGaD
Clomifene—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	2.93e-05	0.00173	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.92e-05	0.00173	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	2.92e-05	0.00173	CbGpPWpGaD
Clomifene—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	2.9e-05	0.00172	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	2.89e-05	0.00171	CbGpPWpGaD
Clomifene—SIGMAR1—medulla oblongata—amyotrophic lateral sclerosis	2.86e-05	0.0335	CbGeAlD
Clomifene—CYP11A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.84e-05	0.00168	CbGpPWpGaD
Clomifene—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.82e-05	0.00167	CbGpPWpGaD
Clomifene—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.78e-05	0.00165	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	2.75e-05	0.00163	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.75e-05	0.00163	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	2.74e-05	0.00162	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.74e-05	0.00162	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.74e-05	0.00162	CbGpPWpGaD
Clomifene—EBP—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.68e-05	0.00159	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	2.67e-05	0.00158	CbGpPWpGaD
Clomifene—CYP1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.66e-05	0.00158	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	2.63e-05	0.00156	CbGpPWpGaD
Clomifene—CYP2A6—cerebellum—amyotrophic lateral sclerosis	2.63e-05	0.0308	CbGeAlD
Clomifene—CYP11A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.62e-05	0.00155	CbGpPWpGaD
Clomifene—CYP1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.62e-05	0.00155	CbGpPWpGaD
Clomifene—CYP11A1—brain—amyotrophic lateral sclerosis	2.58e-05	0.0302	CbGeAlD
Clomifene—SIGMAR1—spinal cord—amyotrophic lateral sclerosis	2.55e-05	0.0299	CbGeAlD
Clomifene—ESR1—Gene Expression—FUS—amyotrophic lateral sclerosis	2.55e-05	0.00151	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	2.54e-05	0.00151	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	2.52e-05	0.0015	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.51e-05	0.00149	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.5e-05	0.00148	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—DAO—amyotrophic lateral sclerosis	2.49e-05	0.00147	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	2.48e-05	0.00147	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	2.47e-05	0.00146	CbGpPWpGaD
Clomifene—EBP—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.46e-05	0.00146	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.39e-05	0.00142	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.39e-05	0.00142	CbGpPWpGaD
Clomifene—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	2.36e-05	0.0014	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.33e-05	0.00138	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.33e-05	0.00138	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.31e-05	0.00137	CbGpPWpGaD
Clomifene—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	2.28e-05	0.0267	CbGeAlD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	2.23e-05	0.00132	CbGpPWpGaD
Clomifene—CYP19A1—nervous system—amyotrophic lateral sclerosis	2.19e-05	0.0256	CbGeAlD
Clomifene—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.19e-05	0.0013	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.16e-05	0.00128	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.16e-05	0.00128	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.16e-05	0.00128	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.14e-05	0.00127	CbGpPWpGaD
Clomifene—CYP2A6—brain—amyotrophic lateral sclerosis	2.13e-05	0.025	CbGeAlD
Clomifene—CYP19A1—central nervous system—amyotrophic lateral sclerosis	2.11e-05	0.0247	CbGeAlD
Clomifene—ESR1—Gene Expression—RARA—amyotrophic lateral sclerosis	2.08e-05	0.00123	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.04e-05	0.00121	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.04e-05	0.00121	CbGpPWpGaD
Clomifene—KCNH2—spinal cord—amyotrophic lateral sclerosis	2.03e-05	0.0238	CbGeAlD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.03e-05	0.0012	CbGpPWpGaD
Clomifene—SIGMAR1—cerebellum—amyotrophic lateral sclerosis	2.03e-05	0.0237	CbGeAlD
Clomifene—EBP—Metabolism—APOE—amyotrophic lateral sclerosis	2.02e-05	0.0012	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	1.99e-05	0.00118	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	1.98e-05	0.00117	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.98e-05	0.00117	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.97e-05	0.00116	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.91e-05	0.00113	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	1.9e-05	0.00113	CbGpPWpGaD
Clomifene—ESR1—nervous system—amyotrophic lateral sclerosis	1.9e-05	0.0223	CbGeAlD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.9e-05	0.00113	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.88e-05	0.00112	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	1.88e-05	0.00111	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	1.87e-05	0.00111	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.86e-05	0.0011	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.84e-05	0.00109	CbGpPWpGaD
Clomifene—ESR1—central nervous system—amyotrophic lateral sclerosis	1.83e-05	0.0214	CbGeAlD
Clomifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.82e-05	0.00108	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	1.8e-05	0.00106	CbGpPWpGaD
Clomifene—ESR1—cerebellum—amyotrophic lateral sclerosis	1.79e-05	0.021	CbGeAlD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.78e-05	0.00105	CbGpPWpGaD
Clomifene—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	1.76e-05	0.0206	CbGeAlD
Clomifene—CYP19A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.74e-05	0.00103	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.73e-05	0.00103	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.73e-05	0.00102	CbGpPWpGaD
Clomifene—KCNH2—nervous system—amyotrophic lateral sclerosis	1.71e-05	0.0201	CbGeAlD
Clomifene—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	1.7e-05	0.00101	CbGpPWpGaD
Clomifene—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.7e-05	0.001	CbGpPWpGaD
Clomifene—CYP19A1—brain—amyotrophic lateral sclerosis	1.67e-05	0.0196	CbGeAlD
Clomifene—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.67e-05	0.000991	CbGpPWpGaD
Clomifene—KCNH2—central nervous system—amyotrophic lateral sclerosis	1.65e-05	0.0193	CbGeAlD
Clomifene—SIGMAR1—brain—amyotrophic lateral sclerosis	1.65e-05	0.0193	CbGeAlD
Clomifene—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.63e-05	0.000965	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.63e-05	0.000964	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.63e-05	0.000964	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	1.62e-05	0.000957	CbGpPWpGaD
Clomifene—KCNH2—cerebellum—amyotrophic lateral sclerosis	1.61e-05	0.0189	CbGeAlD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.6e-05	0.000947	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.58e-05	0.000938	CbGpPWpGaD
Clomifene—CYP2E1—spinal cord—amyotrophic lateral sclerosis	1.57e-05	0.0183	CbGeAlD
Clomifene—ABCB1—embryo—amyotrophic lateral sclerosis	1.57e-05	0.0183	CbGeAlD
Clomifene—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	1.56e-05	0.000926	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.54e-05	0.000909	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.51e-05	0.000893	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.5e-05	0.000888	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.49e-05	0.000882	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	1.47e-05	0.000873	CbGpPWpGaD
Clomifene—ESR1—brain—amyotrophic lateral sclerosis	1.45e-05	0.017	CbGeAlD
Clomifene—CYP1A1—nervous system—amyotrophic lateral sclerosis	1.45e-05	0.0169	CbGeAlD
Clomifene—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.44e-05	0.000855	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.44e-05	0.000855	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.43e-05	0.000845	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	1.41e-05	0.000835	CbGpPWpGaD
Clomifene—CYP1A1—central nervous system—amyotrophic lateral sclerosis	1.39e-05	0.0163	CbGeAlD
Clomifene—EBP—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.39e-05	0.000822	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.38e-05	0.00082	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	1.38e-05	0.000819	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.37e-05	0.000814	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.35e-05	0.000798	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.33e-05	0.000785	CbGpPWpGaD
Clomifene—CYP2E1—nervous system—amyotrophic lateral sclerosis	1.32e-05	0.0154	CbGeAlD
Clomifene—KCNH2—brain—amyotrophic lateral sclerosis	1.31e-05	0.0153	CbGeAlD
Clomifene—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.31e-05	0.000775	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.3e-05	0.000771	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.3e-05	0.000771	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.3e-05	0.00077	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.3e-05	0.00077	CbGpPWpGaD
Clomifene—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.29e-05	0.000765	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.29e-05	0.000762	CbGpPWpGaD
Clomifene—CYP2E1—central nervous system—amyotrophic lateral sclerosis	1.27e-05	0.0149	CbGeAlD
Clomifene—ESR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.26e-05	0.000744	CbGpPWpGaD
Clomifene—CYP2E1—cerebellum—amyotrophic lateral sclerosis	1.24e-05	0.0145	CbGeAlD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.22e-05	0.000723	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.22e-05	0.000721	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.21e-05	0.000718	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.19e-05	0.000704	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.18e-05	0.000702	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.18e-05	0.000697	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.16e-05	0.000686	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.14e-05	0.000675	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.14e-05	0.000673	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.12e-05	0.000662	CbGpPWpGaD
Clomifene—CYP1A1—brain—amyotrophic lateral sclerosis	1.11e-05	0.0129	CbGeAlD
Clomifene—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.11e-05	0.000655	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	1.09e-05	0.000648	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.08e-05	0.00064	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.07e-05	0.000633	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.06e-05	0.00063	CbGpPWpGaD
Clomifene—CYP3A4—nervous system—amyotrophic lateral sclerosis	1.06e-05	0.0124	CbGeAlD
Clomifene—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.04e-05	0.000615	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.03e-05	0.000611	CbGpPWpGaD
Clomifene—CYP3A4—central nervous system—amyotrophic lateral sclerosis	1.02e-05	0.012	CbGeAlD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.01e-05	0.0006	CbGpPWpGaD
Clomifene—CYP2E1—brain—amyotrophic lateral sclerosis	1.01e-05	0.0118	CbGeAlD
Clomifene—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1e-05	0.000594	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1e-05	0.000594	CbGpPWpGaD
Clomifene—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	1e-05	0.0117	CbGeAlD
Clomifene—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	9.4e-06	0.000557	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	9.4e-06	0.000557	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.39e-06	0.000556	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	9.18e-06	0.000543	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.98e-06	0.000532	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.93e-06	0.000529	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.92e-06	0.000528	CbGpPWpGaD
Clomifene—ABCB1—spinal cord—amyotrophic lateral sclerosis	8.92e-06	0.0104	CbGeAlD
Clomifene—CYP11A1—Metabolism—APOE—amyotrophic lateral sclerosis	8.76e-06	0.000519	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.53e-06	0.000505	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.47e-06	0.000501	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	8.23e-06	0.000488	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	8.02e-06	0.000475	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	7.98e-06	0.000472	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.73e-06	0.000457	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.67e-06	0.000454	CbGpPWpGaD
Clomifene—ABCB1—nervous system—amyotrophic lateral sclerosis	7.51e-06	0.0088	CbGeAlD
Clomifene—ESR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.34e-06	0.000435	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	7.25e-06	0.00043	CbGpPWpGaD
Clomifene—ABCB1—central nervous system—amyotrophic lateral sclerosis	7.24e-06	0.00847	CbGeAlD
Clomifene—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	7.12e-06	0.000422	CbGpPWpGaD
Clomifene—ABCB1—cerebellum—amyotrophic lateral sclerosis	7.07e-06	0.00828	CbGeAlD
Clomifene—CYP19A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.05e-06	0.000418	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.89e-06	0.000408	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.76e-06	0.0004	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	6.57e-06	0.000389	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.56e-06	0.000388	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.11e-06	0.000362	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.03e-06	0.000357	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6e-06	0.000355	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.99e-06	0.000355	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—APOE—amyotrophic lateral sclerosis	5.8e-06	0.000344	CbGpPWpGaD
Clomifene—ABCB1—brain—amyotrophic lateral sclerosis	5.74e-06	0.00672	CbGeAlD
Clomifene—ESR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.61e-06	0.000332	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.61e-06	0.000332	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	5.5e-06	0.000326	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	5.4e-06	0.00032	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.29e-06	0.000313	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.28e-06	0.000313	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	5.07e-06	0.0003	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.93e-06	0.000292	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.83e-06	0.000286	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.66e-06	0.000276	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	4.62e-06	0.000273	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.55e-06	0.000269	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.44e-06	0.000263	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.34e-06	0.000257	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.18e-06	0.000248	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	4.17e-06	0.000247	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.98e-06	0.000235	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	3.65e-06	0.000216	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.63e-06	0.000215	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.59e-06	0.000213	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	3.44e-06	0.000204	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.38e-06	0.0002	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.34e-06	0.000198	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.16e-06	0.000187	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.9e-06	0.000172	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.76e-06	0.000164	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	2.75e-06	0.000163	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.67e-06	0.000158	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.61e-06	0.000155	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.5e-06	0.000148	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.36e-06	0.00014	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.34e-06	0.000139	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.24e-06	0.000133	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.19e-06	0.00013	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.06e-06	0.000122	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.88e-06	0.000112	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.77e-06	0.000105	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.69e-06	0.0001	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.5e-06	8.9e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.16e-06	6.87e-05	CbGpPWpGaD
